Company: STAA
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284603
Chunk: 16

Company: STAAR SURGICAL CO
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 16
---
 November 4, 2025, Alcon publicly issued a presentation discussing its perspective on its proposed acquisition of STAAR and recommending that STAAR stockholders should vote in favor of the Merger Proposal.

12

On November 5, 2025, the Board met with members of STAAR’s management and representatives of Citi and Wachtell Lipton. At such meeting, Mr. Farrell provided an update on his ongoing discussions with Mr. Endicott with respect to a potential amendment to the Merger Agreement. The Board considered potential next steps, including requesting that Alcon increase the merger consideration amount in connection with the potential amendment, conducting limited outreach to selected potential interested parties, and commencing a go-shopprocess. The Board discussed such potential alternatives and considered, among other things, (i) the Board’s fiduciary duties to stockholders, (ii) potential perspectives of stockholders and proxy advisors in response to each alternative, (iii) relevant obligations of STAAR under the existing Merger Agreement, (iv) the possibility that a go-shopor other outreach process could maximize stockholder value by facilitating an increase in the price offered by Alcon or an alternative bidder, (v) prior public statements by Broadwood and Yunqi opposing any amendment to provide for a go-shopprocess, (vi) proxy advisory firms’ and certain stockholders’ stated views that STAAR should have solicited and engaged potential alternative bidders prior to signing the Alcon merger agreement, and (vii) the proposed elimination of certain termination fees payable by STAAR, information rights of Alcon during the go-shopperiod and Alcon’s “match” right, which elimination could facilitate a more open and competitive go-shopprocess. Following such discussion, the Board instructed STAAR’s management and advisors to continue discussions with Alcon and provide an update to the Board at a meeting scheduled for the following day.

On November 6, 2025, the Board met with members of STAAR’s management and representatives of Citi and Wachtell Lipton and continued its discussion of whether to proceed with an amendment to the Merger Agreement. The Board discussed, among other things, the term for a possible go-shopperiod, considering that a longer go-shopperiod, on the one hand, could allow more time for potential alternative bidders to complete their evaluation of the Company, but on the other hand, would result in further delays of the Special Meeting, which certain stockholders had urged the Company to avoid.

Also during the